Search Results - "Femia, Matthew R."

TOX is a critical regulator of tumour-specific T cell differentiation by Scott, Andrew C., Dündar, Friederike, Zumbo, Paul, Chandran, Smita S., Klebanoff, Christopher A., Shakiba, Mojdeh, Trivedi, Prerak, Menocal, Laura, Appleby, Heather, Camara, Steven, Zamarin, Dmitriy, Walther, Tyler, Snyder, Alexandra, Femia, Matthew R., Comen, Elizabeth A., Wen, Hannah Y., Hellmann, Matthew D., Anandasabapathy, Niroshana, Liu, Yong, Altorki, Nasser K., Lauer, Peter, Levy, Olivier, Glickman, Michael S., Kaye, Jonathan, Betel, Doron, Philip, Mary, Schietinger, Andrea

“…Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the functional effector or memory T cell states 1 – 6 . Here we…”
Get full text

Mediator subunit MED1 modulates intranuclear dynamics of the thyroid hormone receptor by Femia, Matthew R., Evans, Rochelle M., Zhang, Jibo, Sun, Xiaopeng, Lebegue, Caroline J., Roggero, Vincent R., Allison, Lizabeth A.

“…The thyroid hormone receptors (TRs) mediate thyroid hormone (T3)‐dependent gene expression. The nuclear import and export signals that direct TR shuttling are…”
Get full text

Abstract CN01-03: T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers by Chandran, Smita, Ma, Jiaqi, Klatt, Martin G., Dündar, Friederike, Zumbo, Paul, Femia, Matthew R., Betel, Doron, Scheinberg, David A., Baker, Brian M., Klebanoff, Christopher A.

“…Abstract Background: “Public” neoantigens represent immunogenic epitopes encompassing hotspot mutations in driver oncogenes that are also restricted by common…”
Get full text